Home/Azome Therapeutics/Elliott Gruskin
EG

Elliott Gruskin

Chief Executive Officer

Azome Therapeutics

Azome Therapeutics Pipeline

DrugIndicationPhase
AZM-152Bronchopulmonary Dysplasia (BPD) PreventionPre-clinical